v3.26.1
Stockholders' Equity
6 Months Ended
Jun. 30, 2026
Stockholders' Equity  
Stockholders' Equity

15. Stockholders’ Equity

Common Stock Dividends

For the three months ended

For the six months ended

June 30, 

June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Dividends declared per common share

$

0.82

  ​

$

0.76

$

1.62

  ​

$

1.51

Reconciliation of Outstanding Common Shares

For the three months ended

For the six months ended

June 30, 

June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Beginning balance

 

216,449,333

 

224,971,715

 

217,380,912

 

226,225,161

Shares issued

 

677,847

201,106

2,301,120

1,836,356

Treasury stock acquired

 

(2,491,746)

(1,987,132)

(5,046,598)

(4,875,828)

Ending balance

 

214,635,434

223,185,689

214,635,434

223,185,689

In February 2024, our Board of Directors (“Board”) authorized a share repurchase program of up to $1.5 billion of our outstanding common stock, which was completed in December 2025. In February 2025, our Board authorized a share repurchase program of up to $1.5 billion of our outstanding common stock, which has no expiration date. Shares repurchased under these programs are accounted for as treasury stock, carried at cost and reflected as a reduction to stockholders’ equity.

Other Comprehensive Income

For the three months ended

 

For the six months ended

June 30, 2026

June 30, 2026

  ​ ​ ​

Pre-Tax

  ​ ​ ​

Tax

  ​ ​ ​

After-Tax

  ​ ​ ​

Pre-Tax

  ​ ​ ​

Tax

  ​ ​ ​

After-Tax

(in millions)

Net unrealized gains (losses) on available-for-sale securities during the period

$

186.5

$

(32.4)

$

154.1

$

(611.7)

$

136.4

$

(475.3)

Reclassification adjustment for losses included in net income (1)

 

55.6

(11.8)

43.8

107.4

(22.8)

84.6

Adjustments for assumed changes in amortization patterns

 

(0.2)

0.1

(0.1)

0.4

0.4

Adjustments for assumed changes in policyholder liabilities

 

(2.2)

0.4

(1.8)

9.9

(2.1)

7.8

Net unrealized gains (losses) on available-for-sale securities

 

239.7

(43.7)

196.0

(494.0)

111.5

(382.5)

Net unrealized gains (losses) on derivative instruments during the period

 

(27.7)

5.8

(21.9)

41.2

(8.7)

32.5

Reclassification adjustment for losses included in net income (2)

 

0.1

0.1

0.2

0.2

Adjustments for assumed changes in amortization patterns

0.1

(0.1)

0.1

(0.1)

Net unrealized gains (losses) on derivative instruments

(27.5)

5.7

(21.8)

41.5

(8.8)

32.7

Liability for future policy benefits discount rate remeasurement gain (3)

102.2

(31.4)

70.8

595.1

(134.6)

460.5

Market risk benefit nonperformance risk remeasurement gain (loss) (4)

(2.5)

0.5

(2.0)

0.8

(0.2)

0.6

Foreign currency translation adjustment during the period

28.7

28.7

8.8

(8.8)

Reclassification adjustment for losses included in net income (5)

1.8

1.8

1.5

1.5

Foreign currency translation adjustment

 

30.5

30.5

 

10.3

 

(8.8)

 

1.5

Unrecognized postretirement benefit obligation during the period

3.2

(0.8)

2.4

(2.0)

0.5

(1.5)

Amortization of amounts included in net periodic benefit cost (6)

 

2.1

(0.6)

1.5

6.9

(1.8)

5.1

Net unrecognized postretirement benefit obligation

 

5.3

(1.4)

3.9

4.9

(1.3)

3.6

Other comprehensive income

$

347.7

$

(70.3)

$

277.4

$

158.6

$

(42.2)

$

116.4

For the three months ended

For the six months ended

June 30, 2025

June 30, 2025

  ​ ​ ​

Pre-Tax

  ​ ​ ​

Tax

  ​ ​ ​

After-Tax

  ​ ​ ​

Pre-Tax

  ​ ​ ​

Tax

  ​ ​ ​

After-Tax

(in millions)

Net unrealized gains on available-for-sale securities during the period

$

273.5

$

(57.6)

$

215.9

$

940.3

$

(198.5)

$

741.8

Reclassification adjustment for losses included in net income (1)

 

44.5

 

(9.5)

35.0

107.0

(22.6)

84.4

Adjustments for assumed changes in amortization patterns

 

(0.1)

 

0.1

(0.5)

0.2

(0.3)

Adjustments for assumed changes in policyholder liabilities

 

(2.6)

 

0.6

(2.0)

15.7

(3.3)

12.4

Net unrealized gains on available-for-sale securities

 

315.3

 

(66.4)

248.9

1,062.5

(224.2)

838.3

Net unrealized losses on derivative instruments during the period

 

(208.0)

 

43.6

(164.4)

(189.5)

39.7

(149.8)

Reclassification adjustment for gains included in net income (2)

 

(0.6)

 

0.2

(0.4)

(1.2)

0.3

(0.9)

Adjustments for assumed changes in amortization patterns

0.1

0.1

0.1

0.1

Net unrealized losses on derivative instruments

 

(208.5)

 

43.8

(164.7)

(190.6)

40.0

(150.6)

Liability for future policy benefits discount rate remeasurement loss (3)

(107.2)

24.7

(82.5)

(419.6)

87.3

(332.3)

Market risk benefit nonperformance risk remeasurement gain (loss) (4)

(0.5)

0.1

(0.4)

2.2

(0.5)

1.7

Foreign currency translation adjustment

89.6

(7.3)

82.3

163.7

(8.0)

155.7

Unrecognized postretirement benefit obligation during the period

(13.6)

3.5

(10.1)

(13.6)

3.5

(10.1)

Amortization of amounts included in net periodic benefit cost (6)

 

4.8

(1.3)

3.5

8.6

(2.2)

6.4

Net unrecognized postretirement benefit obligation

 

(8.8)

2.2

(6.6)

(5.0)

1.3

(3.7)

Other comprehensive income

$

79.9

$

(2.9)

$

77.0

$

613.2

$

(104.1)

$

509.1

(1)Pre-tax reclassification adjustments relating to available-for-sale securities are reported in net realized capital gains (losses) and net realized capital gains (losses) on funds withheld assets on the consolidated statements of operations.
(2)See Note 4, Derivative Financial Instruments, under the caption “Effect of Fair Value and Cash Flow Hedges on Consolidated Statements of Operations” for further details.
(3)Includes the discount rate remeasurement gain (loss) associated with the LFPB and the associated reinsurance recoverable. See Note 8, Future Policy Benefits and Claims, under the caption “Liability for Future Policy Benefits” for further details.
(4)See Note 9, Market Risk Benefits, for further details.
(5)Relates to the release of cumulative translation adjustments from the dissolution of foreign subsidiaries.
(6)Amount is comprised of amortization of prior service cost (benefit) and recognized net actuarial (gain) loss, which is reported in operating expenses on the consolidated statements of operations. See Note 13, Employee and Agent Benefits, under the caption “Components of Net Periodic Benefit Cost” for further details.

Accumulated Other Comprehensive Loss

MRB

Net unrealized

Net unrealized

LFPB 

nonperformance

Foreign

Unrecognized

Accumulated

losses on

gains (losses)

discount rate

risk

currency

postretirement

other

available-for-sale 

on derivative

remeasurement

remeasurement

translation

benefit

comprehensive

  ​ ​ ​

securities (1)

  ​ ​ ​

instruments

  ​ ​ ​

gain

  ​ ​ ​

loss

  ​ ​ ​

adjustment

  ​ ​ ​

obligation

  ​ ​ ​

loss

(in millions)

Balances as of April 1, 2025

$

(4,103.5)

$

65.9

$

1,188.4

$

(12.9)

$

(1,705.7)

$

(218.1)

$

(4,785.9)

Other comprehensive income during the period, net of adjustments

 

213.9

 

(164.3)

 

(82.5)

 

(0.4)

 

77.9

 

(10.1)

 

34.5

Amounts reclassified from AOCI

 

35.0

 

(0.4)

 

 

 

 

3.5

 

38.1

Other comprehensive income

 

248.9

 

(164.7)

 

(82.5)

 

(0.4)

 

77.9

 

(6.6)

 

72.6

Balances as of June 30, 2025

$

(3,854.6)

$

(98.8)

$

1,105.9

$

(13.3)

$

(1,627.8)

$

(224.7)

$

(4,713.3)

Balances as of April 1, 2026

$

(3,807.6)

$

22.6

$

1,202.2

$

(10.8)

$

(1,569.9)

$

(180.2)

$

(4,343.7)

Other comprehensive income during the period, net of adjustments

152.2

(21.9)

70.8

(2.0)

29.3

2.4

230.8

Amounts reclassified from AOCI

43.8

0.1

1.7

1.5

47.1

Other comprehensive income

196.0

(21.8)

70.8

(2.0)

31.0

3.9

277.9

Balances as of June 30, 2026

$

(3,611.6)

$

0.8

$

1,273.0

$

(12.8)

$

(1,538.9)

$

(176.3)

$

(4,065.8)

MRB

Net unrealized

Net unrealized

LFPB

nonperformance

Foreign

Unrecognized

Accumulated

losses on

gains (losses)

discount rate

risk

currency

postretirement

other

available-for-sale

on derivative

remeasurement

remeasurement

translation

benefit

comprehensive

  ​ ​ ​

securities (1)

  ​ ​ ​

instruments

  ​ ​ ​

gain

  ​ ​ ​

loss

  ​ ​ ​

adjustment

  ​ ​ ​

obligation

  ​ ​ ​

loss

(in millions)

Balances as of January 1, 2025

$

(4,692.9)

$

51.8

$

1,438.2

$

(15.0)

$

(1,785.9)

$

(221.0)

$

(5,224.8)

Other comprehensive income during the period, net of adjustments

 

753.9

(149.7)

(332.3)

1.7

158.1

(10.1)

421.6

Amounts reclassified from AOCI

 

84.4

(0.9)

6.4

89.9

Other comprehensive income

 

838.3

(150.6)

(332.3)

1.7

158.1

(3.7)

511.5

Balances as of June 30, 2025

$

(3,854.6)

$

(98.8)

$

1,105.9

$

(13.3)

$

(1,627.8)

$

(224.7)

$

(4,713.3)

Balances as of January 1, 2026

$

(3,229.1)

$

(31.9)

$

812.5

$

(13.4)

$

(1,546.6)

$

(179.9)

$

(4,188.4)

Other comprehensive income during the period, net of adjustments

 

(467.1)

32.5

460.5

0.6

6.3

(1.5)

31.3

Amounts reclassified from AOCI

 

84.6

0.2

1.4

5.1

91.3

Other comprehensive income

 

(382.5)

32.7

460.5

0.6

7.7

3.6

122.6

Balances as of June 30, 2026

$

(3,611.6)

$

0.8

$

1,273.0

$

(12.8)

$

(1,538.9)

$

(176.3)

$

(4,065.8)

(1)Net unrealized losses on available-for-sale securities for which an allowance for credit loss has been recorded were $12.1 million and $4.5 million as of June 30, 2026 and 2025, respectively.

Noncontrolling Interest

Interests held by unaffiliated parties in consolidated entities are reflected in noncontrolling interest, which represents the noncontrolling partners’ share of the underlying net assets of our consolidated subsidiaries. Noncontrolling interest that is not redeemable is reported in the equity section of the consolidated statements of financial position.

The noncontrolling interest holders in certain of our consolidated entities maintain an equity interest that is redeemable at the option of the holder, which may be exercised on varying dates. Since redemption of the noncontrolling interest is outside of our control, this interest is excluded from stockholders’ equity and reported separately as redeemable noncontrolling interest on the consolidated statements of financial position. Our redeemable noncontrolling interest primarily relates to consolidated sponsored investment funds for which interests are redeemed at fair value from the net assets of the funds.

For our redeemable noncontrolling interest related to other consolidated subsidiaries, redemptions are required to be purchased at fair value or a value based on a formula that management intended to reasonably approximate fair value based on a fixed multiple of earnings over a measurement period. The carrying value of the redeemable noncontrolling interest is compared to the redemption value at each reporting period. Any adjustments to the carrying amount of the redeemable noncontrolling interest for changes in redemption value prior to exercise of the redemption option are determined after the attribution of net income or loss of the subsidiary and are recognized in the redemption value as they occur. Adjustments to the carrying value of redeemable noncontrolling interest result in adjustments to additional paid-in capital and/or retained earnings. Adjustments are recorded in retained earnings to the extent the redemption value of the redeemable noncontrolling interest exceeds its fair value and will impact the numerator in our earnings per share calculations. All other adjustments to the redeemable noncontrolling interest are recorded in additional paid-in capital.

Following is a reconciliation of the changes in the redeemable noncontrolling interest:

For the three months ended

For the six months ended

June 30, 

June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

(in millions)

Beginning balance

$

544.1

$

326.7

$

474.3

$

337.7

Net income attributable to redeemable noncontrolling interest

26.3

25.9

 

14.2

 

37.4

Redeemable noncontrolling interest of deconsolidated entities (1)

(0.2)

(10.4)

(7.5)

(22.9)

Contributions from redeemable noncontrolling interest

157.3

58.1

283.4

88.9

Distributions to redeemable noncontrolling interest

(15.1)

(13.3)

 

(46.0)

 

(45.1)

Purchase of subsidiary shares from redeemable noncontrolling interest

(0.9)

(1.6)

Stock-based compensation attributable to redeemable noncontrolling interest

0.1

0.1

Other comprehensive income (loss) attributable to redeemable noncontrolling interest

(0.7)

4.1

(5.8)

(3.3)

Ending balance

$

711.7

$

391.2

$

711.7

$

391.2

(1)We deconsolidated certain sponsored investment funds as they no longer met the requirements for consolidation.